Hitoshi Kiyoi

22PUBLICATIONS
86CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersHaematological tumoursTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jun 18, 2026
Treatment-Free Remission and Immune Profiling after Frontline Second-Generation TKI Therapy in CML.

|Jun 11, 2026
Early predictors of MR4.5 attainment and eligibility for TKI discontinuation in CML treated with second-generation TKIs.

|Apr 07, 2026
Ponatinib inhibits LCK and PI3K signaling and promotes CD8<sup>+</sup> T stem cell memory cell development.

Yuki Okuhiro, Sachiko Ito, Keisuke Watanabe

|Jan 07, 2026
NUP98 rearrangements in adult AML patients: evaluation of clinical implications and identification of novel fusion partners.

Kazuhisa Chonabayashi, Makoto Iwasaki, Junya Kanda

|Dec 10, 2024
Cullin-5 deficiency promotes chimeric antigen receptor T cell effector functions potentially via the modulation of JAK/STAT signaling pathway.

Yoshitaka Adachi, Seitaro Terakura, Masahide Osaki

|Nov 21, 2024
Nelarabine-combined chemotherapy improves outcome of T-cell acute lymphoblastic leukemia but shows more severe neurotoxicity: JALSG T-ALL213-O.

Fumihiko Hayakawa, Naoki Mori, Kiyotoshi Imai

Pageof 4

Frequent Collaborators

6 joint publications

Itaru Matsumura

5 joint publications

Kazuyuki Shimada

4 joint publications

Seitaro Terakura

4 joint publications

Emiko Sakaida